Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-03-004934
Filing Date
2003-02-12
Accepted
2003-02-12 14:28:34
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a2103003zsc13ga.htm SC 13G/A 80851
3 EX-99.1 a2103003zex-99_1.htm EX-99.1 10879
  Complete submission text file 0001047469-03-004934.txt   94119
Mailing Address 665 STOCKTON DRIVE SUITE 104 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 104 EXTON PA 19341 6104588959
3 DIMENSIONAL PHARMACEUTICALS INC (Subject) CIK: 0000914201 (see all company filings)

EIN.: 232716487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59449 | Film No.: 03553872
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice